Skip to main content
Terug
Watch Compare

Silo Pharma, Inc.

Datakwaliteit: 100%
SILO
Nasdaq Manufacturing Chemicals
€ 0,42
▼ € 0,03 (-5,88%)
Marktkapitalisatie: 6,77 M
Prijs
€ 0,42
Marktkapitalisatie
6,77 M
Dagbereik
€ 0,38 — € 0,42
52-Weeksbereik
€ 0,22 — € 1,19
Volume
1.748.730
Openen € 0,38
50D / 200D Gem.
€ 0,34
23,77% above
50D / 200D Gem.
€ 0,51
17,79% below

Quick Summary

Belangrijkste Punten

Negative free cash flow of -4,66 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)0,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-85,18%
Onder sectorgemiddelde (-53,41%)
ROIC-59,97%
Net Margin-5863,50%
Op. Margin-5936,95%

Veiligheid

Debt / Equity
N/A
Current Ratio8,70
Interest Coverage-114,76

Waardering

PE (TTM)
-1,60
Onder sectorgemiddelde (-1,48)
P/B Ratio1,35
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -1,6 -1,5
P/B 1,4 1,6
ROE % -85,2 -53,4
Net Margin % -5863,5 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

PSIL logo PSIL AdvisorShares Psychedelics ETF
1,47% weight
AVXC logo AVXC Avantis Emerging Markets ex-China Equity ETF
0,02% weight
AVES logo AVES Avantis Emerging Markets Value ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 0,00% Revenue Growth (3Y) 0,00%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 72.102,0 Net Income (TTM) -4,23 M
ROE -85,18% ROA -64,86%
Gross Margin 38,57% Operating Margin -5936,95%
Net Margin -5863,50% Free Cash Flow (TTM) -4,66 M
ROIC -59,97% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 8,70
Interest Coverage -114,76 Asset Turnover 0,01
Working Capital 5,46 M Tangible Book Value 4,79 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,60 Forward P/E N/A
P/B Ratio 1,35 P/S Ratio 93,83
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -68,90%
Market Cap 6,77 M Enterprise Value 2,85 M
Per Share
EPS (Diluted TTM) -0,50 Revenue / Share 0,00
FCF / Share -0,29 OCF / Share -0,29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 110,26%
SBC-Adj. FCF -4,89 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 72.102,0 72.102,0 72.102,0 — —
Net Income -4,23 M -4,39 M -3,70 M -3,91 M 3,90 M
EPS (Diluted) -0,50 -1,19 — — 0,04
Gross Profit 27.807,0 66.264,0 66.264,0 66.264,0 66.260,0
Operating Income -4,28 M -4,71 M -3,86 M -3,63 M -2,74 M
EBITDA — — — — —
R&D Expenses 2,16 M 2,37 M 845.092,0 1,29 M 693.910,0
SG&A Expenses — — 390.071,0 227.259,0 162.953,0
D&A — — — — —
Interest Expense 37.302,0 5.084,0 4.869,0 2.199,0 54,0
Income Tax — — — 24.876,0 24.876,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 7,61 M 7,41 M 7,75 M 11,64 M 10,49 M
Total Liabilities 1,30 M 2,38 M 1,57 M 1,30 M 1,43 M
Shareholders' Equity 6,31 M 5,03 M 6,18 M 10,34 M 9,06 M
Total Debt — — — — —
Cash & Equivalents 4,75 M 3,91 M 3,52 M 11,37 M 9,84 M
Current Assets 7,39 M 7,11 M 7,68 M 11,57 M 10,40 M
Current Liabilities 650.183,0 1,66 M 775.590,0 436.318,0 490.039,0